Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to shift the market?

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Ozempic copycats could come with hefty price tags as FDA declares end of semaglutide shortage Trump ... See the New Images From the Approach Tesla Stock Gets Some Good News as Elon Musk Announces ...

While Berberine is touted as a natural alternative to Ozempic, its AMPK modulation differs from GLP-1 pathways, highlighting ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019. Is it time to buy the dip in Novo Nordisk stock? With a history dating back ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.

Novo Nordisk A/S Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...